跳至主要内容
临床试验/JPRN-UMIN000005957
JPRN-UMIN000005957招募中未知

Evaluation of safety of percutaneous radiofrequency ablation therapy for metastatic or primary lung cancer - Evaluation of safety of percutaneous radiofrequency ablation therapy for metastatic or primary lung cancer

Oita University Faculty of Medicine, Department of Radiology0 个研究点目标入组 20 人开始时间: 2011年7月15日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • Lesion adjacent to large vessels Cases with active infection Cases with active asthma Cases undergone unilateral pneumonectomy Cases whose performance status is over grade 3 Blood cell count: WBC<2,000/ul, granulocyte<1,000/ul Platelet<5x104/ul or PT-INR>1.5 Forced expiratory volume<1L Cases deemed to be inadequate for this treatment

研究者

发起方
Oita University Faculty of Medicine, Department of Radiology

相似试验